dinutuximab - CAS 1363687-32-4
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C6422H9982N1722O2008S48
Molecular Weight:
145000
COA:
Inquire
Targets:
GD2
Description:
Dinutuximab is an anti-GD2 monoclonal antibody. Dinutuximab beta was approved for the treatment of patients with high-risk neuroblastoma. In combination with interleukin-2, dinutuximab beta is used to treat those who have not achieved a complete response after first-line therapy.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
anti-GD2 monoclonal antibody, high-risk neuroblastoma
MSDS:
Inquire
Application:
the treatment of patients with high-risk neuroblastoma
Current Developer:
EUSA Pharma
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items